ORKAMBI (TM) FOR PATIENTS WITH FEV1 < 40%: SIX MONTHS' OUTCOMES INCLUDING ALFRED WELLNESS SCORE "AWESCORE," EXERCISE CAPACITY, AND LUNG FUNCTION Conference Paper uri icon

authors

  • Button, BM
  • Wison, LM
  • Williams, F
  • King, SJ
  • Talbot, A
  • Keating, D
  • Wilson, JW

publication date

  • September 1, 2017